Form 25-NSE Dermata Therapeutics, Filed by: Nasdaq Stock Market LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ribo Submits European Clinical Trial Application for Phase Ⅰ Study of INHBE-Targeting siRNA RBD3133
- Solana Price Drops With the Wider Market as Remittix’s Confirmed Launch Date Holds Firm
- Resecurity Appoints Former FBI Cyber Leader Jerry Bessette to Advisory Board as Senior Advisor
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share